author-photo

Cheryl Nickerson-Nutter

Pfizer

49

Papers

2016

Citations

Citation Trend

Filter By

Papers (32) Sort By

Journal Conference Others

Targeted inhibition of PI3 kinase/mTOR specifically in fibrotic lung fibroblasts suppresses pulmonary fibrosis in experimental models

2020 Science Translational Medicine
Show All
- Source
- Cite
- Save
Citations (5)
Depletion of activated macrophages with a folate receptor-beta-specific antibody improves symptoms in mouse models of rheumatoid arthritis

2019 Arthritis Research & Therapy
Show All
- Source
- Cite
- Save
Citations (17)
Modeling the Clinical Phenotype of BTK Inhibition in the Mature Murine Immune System

2014 Journal of Immunology
Show All
- Source
- Cite
- Save
Citations (17)
Interleukin-21 Receptor Deficiency Increases the Initial Toll-like Receptor 2 Response but Protects Against Joint Pathology by Reducing Th1 and Th17 Cells During Streptococcal Cell Wall Arthritis

2014 Arthritis & Rheumatism
Show All
- Source
- Cite
- Save
Citations (21)
A3.5 Combination Blocking of IL-6 and IL-21 in Experimental Arthritis Inhibits their Redundant Role in Th17-Driven Joint Pathology

2013 Annals of the Rheumatic Diseases
Show All
- Source
- Cite
- Save
Citations (0)
In vivo imaging implicates CCR2+ monocytes as regulators of neutrophil recruitment during arthritis

2012 Cellular Immunology
Show All
- Source
- Cite
- Save
Citations (24)
Increased innate immune responses by interleukin-22 contributes to the inflammatory process in rheumatoid arthritis

2012 Annals of the Rheumatic Diseases
Show All
- Source
- Cite
- Save
Citations (0)
Imidazo(1,5-a)quinoxalines as irreversible BTK inhibitors for the treatment of rheumatoid arthritis

2011 Bioorganic & Medicinal Chemistry Letters
Show All
- Source
- Cite
- Save
Citations (52)
Increased IL-22 expression by synovial Th17 cells during late stages of arthritis is controlled by IL-1 and enhances bone degradation

2011 Annals of the Rheumatic Diseases
Show All
- Source
- Cite
- Save
Citations (0)
Distinct in vitro binding properties of the anti-CD20 small modular immunopharmaceutical 2LM20-4 result in profound and sustained in vivo potency in cynomolgus monkeys

2011 Rheumatology
Show All
- Source
- Cite
- Save
Citations (8)